These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 26374485

  • 1. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.
    Chen Z, Lan X, Wu D, Sunkel B, Ye Z, Huang J, Liu Z, Clinton SK, Jin VX, Wang Q.
    Nat Commun; 2015 Sep 16; 6():8323. PubMed ID: 26374485
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy.
    Orqueda AJ, Dansey MV, Español A, Veleiro AS, Bal de Kier Joffé E, Sales ME, Burton G, Pecci A.
    Biochem Pharmacol; 2014 Jun 15; 89(4):526-35. PubMed ID: 24735610
    [Abstract] [Full Text] [Related]

  • 5. Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.
    Lesovaya EA, Yemelyanov AY, Kirsanov KI, Yakubovskaya MG, Budunova IV.
    Biochemistry (Mosc); 2011 Nov 15; 76(11):1242-52. PubMed ID: 22117551
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
    Clarisse D, Van Wesemael K, Tavernier J, Offner F, Beck IM, De Bosscher K.
    PLoS One; 2018 Nov 15; 13(5):e0197000. PubMed ID: 29738549
    [Abstract] [Full Text] [Related]

  • 8. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells.
    Riml S, Schmidt S, Ausserlechner MJ, Geley S, Kofler R.
    Cell Death Differ; 2004 Jul 15; 11 Suppl 1():S65-72. PubMed ID: 15017388
    [Abstract] [Full Text] [Related]

  • 9. Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.
    Kanai A, McNamara KM, Iwabuchi E, Miki Y, Onodera Y, Guestini F, Khalid F, Sagara Y, Ohi Y, Rai Y, Yamaguchi R, Tanaka M, Miyashita M, Ishida T, Sasano H.
    Breast Cancer Res Treat; 2020 Feb 15; 180(1):97-110. PubMed ID: 31989378
    [Abstract] [Full Text] [Related]

  • 10. Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts.
    Gossye V, Elewaut D, Bougarne N, Bracke D, Van Calenbergh S, Haegeman G, De Bosscher K.
    Arthritis Rheum; 2009 Nov 15; 60(11):3241-50. PubMed ID: 19877072
    [Abstract] [Full Text] [Related]

  • 11. Interplay of the inflammatory and stress systems in a hepatic cell line: interactions between glucocorticoid receptor agonists and interleukin-6.
    Visser K, Smith C, Louw A.
    Endocrinology; 2010 Nov 15; 151(11):5279-93. PubMed ID: 20881254
    [Abstract] [Full Text] [Related]

  • 12. GR-independent down-modulation on GM-CSF bone marrow-derived dendritic cells by the selective glucocorticoid receptor modulator Compound A.
    Barcala Tabarrozzi AE, Andreone L, Deckers J, Castro CN, Gimeno ML, Ariolfo L, Berguer PM, Antunica-Noguerol M, Liberman AC, Vettorazzi S, Tuckermann JP, De Bosscher K, Perone MJ.
    Sci Rep; 2016 Nov 18; 6():36646. PubMed ID: 27857212
    [Abstract] [Full Text] [Related]

  • 13. A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistance.
    Gossye V, Elewaut D, Van Beneden K, Dewint P, Haegeman G, De Bosscher K.
    Ann Rheum Dis; 2010 Jan 18; 69(1):291-6. PubMed ID: 19204014
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and Anti-Cancer Activity of the Novel Selective Glucocorticoid Receptor Agonists of the Phenylethanolamine Series.
    Zhidkova EM, Tilova LR, Fetisov TI, Kirsanov KI, Kulikov EP, Enikeev AD, Budunova IV, Badun GA, Chernysheva MG, Shirinian VZ, Yakubovskaya MG, Lesovaya EA.
    Int J Mol Sci; 2024 Aug 15; 25(16):. PubMed ID: 39201590
    [Abstract] [Full Text] [Related]

  • 15. The Role of Glucocorticoids in Breast Cancer Therapy.
    Mitre-Aguilar IB, Moreno-Mitre D, Melendez-Zajgla J, Maldonado V, Jacobo-Herrera NJ, Ramirez-Gonzalez V, Mendoza-Almanza G.
    Curr Oncol; 2022 Dec 25; 30(1):298-314. PubMed ID: 36661673
    [Abstract] [Full Text] [Related]

  • 16. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A, Czwornog J, Gera L, Joshi S, Chatterton RT, Budunova I.
    Cancer Res; 2008 Jun 15; 68(12):4763-73. PubMed ID: 18559523
    [Abstract] [Full Text] [Related]

  • 17. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.
    Thomas AL, Coarfa C, Qian J, Wilkerson JJ, Rajapakshe K, Krett NL, Gunaratne PH, Rosen ST.
    Nucl Recept Signal; 2015 Jun 15; 13():e006. PubMed ID: 26715915
    [Abstract] [Full Text] [Related]

  • 18. Quantitative analysis and modeling of glucocorticoid-controlled gene expression.
    Chen DW, Lynch JT, Demonacos C, Krstic-Demonacos M, Schwartz JM.
    Pharmacogenomics; 2010 Nov 15; 11(11):1545-60. PubMed ID: 21121775
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoid receptors orchestrate a convergence of host and cellular stress signals in triple negative breast cancer.
    Posani SH, Gillis NE, Lange CA.
    J Steroid Biochem Mol Biol; 2024 Oct 15; 243():106575. PubMed ID: 38950871
    [Abstract] [Full Text] [Related]

  • 20. Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.
    Buschmann D, González R, Kirchner B, Mazzone C, Pfaffl MW, Schelling G, Steinlein O, Reithmair M.
    Int J Oncol; 2018 Jun 15; 52(6):1765-1776. PubMed ID: 29620157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.